Lobe Sciences Ltd.
LOBEF
$0.04
$0.004.65%
OTC PK
| 08/31/2025 | 05/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 100.62% | 26.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 80.00% | 68.86% | |||
| Operating Income | -80.00% | -68.86% | |||
| Income Before Tax | -100.81% | -64.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -100.81% | -64.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 93.18% | -- | |||
| Net Income | -101.97% | -42.50% | |||
| EBIT | -80.00% | -68.86% | |||
| EBITDA | -81.59% | -71.17% | |||
| EPS Basic | -19,791.67% | -38.46% | |||
| Normalized Basic EPS | -21,614.29% | -10.53% | |||
| EPS Diluted | -19,791.67% | -38.46% | |||
| Normalized Diluted EPS | -21,614.29% | -10.53% | |||
| Average Basic Shares Outstanding | -98.98% | 3.43% | |||
| Average Diluted Shares Outstanding | -98.98% | 3.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||